LYTIR

Company · VNDA

Vanda Pharmaceuticals Inc.

Nasdaq's symbol directory lists VNDA on Nasdaq as “Vanda Pharmaceuticals Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 3 occasions ($38K); 6 filings by holders of 5% or more.

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Charles Cliff Duncan bought on 3 days latest Nov 5, 2026 bought $38K
Every trade (3)
  1. BUYCharles Cliff Duncan bought Nov 5, 2026 5,803 shares filing $22K
  2. BUYCharles Cliff Duncan bought Nov 4, 2026 3,447 shares filing $13K
  3. BUYCharles Cliff Duncan bought Nov 3, 2026 750 shares filing $3K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. AQR Capital Management, LLC filed Nov 13, 2026 Schedule 13G/A passive 2,096,939 shares filing 3.47%
  2. STATE STREET CORPORATION filed Nov 10, 2026 Schedule 13G passive 3,010,531 shares filing 5%
  3. BlackRock Portfolio Management LLC filed Oct 27, 2026 Schedule 13G passive 3,587,013 shares filing 5.9%
  4. Millennium Management LLC filed Oct 9, 2026 Schedule 13G/A passive filing 7%
  5. Millennium Management LLC filed Aug 19, 2026 Schedule 13G passive filing 5.6%
  6. AQR Capital Management, LLC filed Aug 13, 2026 Schedule 13G passive 3,497,695 shares filing 5.82%

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.